Glenmark Pharmaceuticals Ltd

Glenmark Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Glenmark Pharmaceuticals Ltd

₹ 1,623 0.41%
11 Jun 10:48 a.m.
glenmarkpharma.com BSE: 532296 NSE: GLENMARK
About

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]

Key Points

Leadership[1]

<h1>14th largest and fastest growing in the Indian market</h1> <h1>15th largest generic company by prescriptions filled in the USA</h1> <h1>5th largest Indian generic co. in Europe.</h1>
Website BSE NSE
  • Market Cap ₹ 45,791 Cr.
  • Current Price ₹ 1,623
  • High / Low ₹ 1,831 / 1,182
  • Stock P/E 26.3
  • Book Value ₹ 868
  • Dividend Yield 0.15 %
  • ROCE 9.72 %
  • ROE 7.35 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 6.57% over past five years.
  • Company has a low return on equity of 7.72% over last 3 years.
  • Dividend payout has been low at 3.86% of profits over last 3 years
  • Working capital days have increased from 60.2 days to 84.5 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE MidCap Nifty Pharma

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,786 1,912 2,208 2,161 1,939 2,144 2,233 1,365 2,148 2,330 2,636 2,251 2,010
1,624 1,478 1,826 1,723 1,721 1,659 1,790 1,549 1,651 1,698 1,857 1,757 1,669
Operating Profit 162 434 382 439 218 485 443 -184 497 631 779 494 341
OPM % 9% 23% 17% 20% 11% 23% 20% -14% 23% 27% 30% 22% 17%
179 347 317 252 -425 18 54 234 5,933 56 83 129 -91
Interest 74 40 52 56 59 62 58 74 83 15 12 8 13
Depreciation 42 45 46 46 47 49 50 51 52 53 55 55 56
Profit before tax 225 696 601 589 -313 392 389 -76 6,295 618 795 559 181
Tax % 9% 29% 30% 27% -56% 31% 22% -73% 27% 27% 25% 26% 18%
206 493 423 430 -137 272 302 -20 4,614 454 595 414 148
EPS in Rs 7.29 17.46 15.00 15.26 -4.87 9.63 10.72 -0.72 163.50 16.08 21.09 14.66 5.24
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2,301 5,086 6,115 7,989 5,520 6,305 6,713 7,568 8,142 8,221 7,891 9,226
1,805 3,618 4,349 5,089 4,417 4,977 5,407 5,676 6,453 6,748 6,649 6,982
Operating Profit 496 1,467 1,766 2,900 1,103 1,328 1,305 1,892 1,689 1,473 1,242 2,244
OPM % 22% 29% 29% 36% 20% 21% 19% 25% 21% 18% 16% 24%
67 -86 116 -89 326 954 624 469 1,044 490 6,238 177
Interest 31 30 36 153 191 224 256 266 236 207 277 49
Depreciation 30 119 100 105 96 106 139 151 160 184 202 219
Profit before tax 502 1,232 1,747 2,553 1,143 1,952 1,535 1,944 2,337 1,572 7,001 2,154
Tax % 14% 18% 15% 16% 11% 17% 12% 15% 15% 23% 26% 25%
434 1,008 1,484 2,141 1,014 1,622 1,355 1,649 1,998 1,209 5,167 1,610
EPS in Rs 15.99 37.14 52.60 75.86 35.95 57.49 48.01 58.46 70.80 42.84 183.12 57.07
Dividend Payout % 12% 5% 4% 3% 6% 3% 5% 4% 4% 6% 1% 4%
Compounded Sales Growth
10 Years: 6%
5 Years: 7%
3 Years: 4%
TTM: 17%
Compounded Profit Growth
10 Years: 4%
5 Years: 5%
3 Years: 2%
TTM: 22%
Stock Price CAGR
10 Years: 6%
5 Years: 32%
3 Years: 61%
1 Year: 36%
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 8%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 27 27 28 28 28 28 28 28 28 28 28 28
Reserves 2,879 4,925 7,338 9,408 10,363 11,914 13,198 14,781 16,710 17,849 22,942 24,476
353 410 787 2,777 2,981 3,134 3,574 3,704 3,738 3,221 707 830
970 2,289 1,960 1,787 1,892 2,066 2,152 2,104 2,438 3,487 3,736 2,700
Total Liabilities 4,230 7,651 10,113 14,001 15,265 17,143 18,952 20,618 22,914 24,586 27,414 28,033
449 1,231 1,438 1,596 1,699 1,413 1,612 1,722 1,752 1,746 1,756 2,012
CWIP 83 294 276 271 420 286 200 131 109 172 198 121
Investments 1,409 1,660 1,858 1,867 3,213 3,269 4,714 6,990 8,559 10,333 12,965 15,195
2,289 4,466 6,541 10,267 9,933 12,174 12,426 11,774 12,494 12,335 12,496 10,705
Total Assets 4,230 7,651 10,113 14,001 15,265 17,143 18,952 20,618 22,914 24,586 27,414 28,033

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
114 145 355 878 1,124 2,490 1,579 1,243 1,216 1,474 -495 59
211 -176 -1,545 -2,580 -1,137 -2,256 -1,607 -1,235 -897 -432 3,197 -49
-385 -32 1,223 1,879 -62 -155 -139 -81 -305 -978 -2,666 -10
Net Cash Flow -60 -64 32 177 -75 79 -168 -73 14 64 35 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 180 175 182 177 253 121 100 120 120 111 115 101
Inventory Days 126 161 182 172 195 141 115 94 100 117 130 156
Days Payable 337 343 306 221 273 258 217 201 205 225 307 242
Cash Conversion Cycle -31 -6 59 129 175 4 -3 14 16 3 -62 15
Working Capital Days 98 104 155 179 252 168 130 141 92 52 44 84
ROCE % 17% 33% 26% 29% 10% 13% 11% 12% 11% 11% 10% 10%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65%
24.23% 23.14% 23.19% 22.47% 25.51% 24.79% 23.71% 21.38% 20.98% 23.05% 23.51% 23.15%
10.50% 10.90% 10.69% 10.40% 9.10% 10.31% 10.92% 13.36% 13.93% 13.21% 13.85% 14.60%
0.00% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
18.63% 19.27% 19.45% 20.46% 18.70% 18.21% 18.70% 18.58% 18.42% 17.06% 15.96% 15.56%
No. of Shareholders 3,12,4733,13,5403,00,1062,85,4612,36,9082,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,724

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls